OAM
ALPN

Oxford Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Oxford Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,919
Closed -$134K – 1938
2017
Q4 		$134K Sell
11,919
-550
-4% -$5.99K ﹤0.01% 1504
2017
Q3 		$144K Buy
+12,469
New +$117K ﹤0.01% 1458

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Oxford Asset Management's ALPN Position: Q1 2018 in Review

Oxford Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2018, closing a stake of 11,919 shares — an estimated $134K sold.

Oxford Asset Management first reported a position in ALPN in Q3 2017 and held it in 2 quarters. The position peaked at $144K in Q3 2017. 28 funds tracked by Wall St. Rank hold ALPN as of Q1 2018.

  • Oxford Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q1 2018 after selling out during the quarter.
  • Oxford Asset Management sold 11,919 Alpine Immune Sciences Inc shares in Q1 2018, an estimated $134K.
  • Oxford Asset Management first reported a position in Alpine Immune Sciences Inc in Q3 2017 and held it in 2 quarters.
  • Oxford Asset Management's Alpine Immune Sciences Inc position peaked at $144K in Q3 2017.
  • 28 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2018.

Based on Oxford Asset Management's 13F filing for Q1 2018, filed 15 May 2018.